Meadowhawk Biolabs, Inc.

Meadowhawk Biolabs, Inc. is a preclinical Contract Research Organization (CRO) founded in 2021. The company specializes in bioanalytical, pharmacokinetic, pharmacology, and in vivo services aimed at accelerating drug discovery and development for pharmaceutical and biotech clients. Headquartered in Marlborough, Massachusetts, Meadowhawk operates state-of-the-art, AAALAC-accredited laboratories in Boston and San Francisco, allowing for rapid study starts in as little as 24 hours. With a leadership team boasting over 30 years of combined experience in biotech, Meadowhawk emphasizes adaptability and precision in its services. The company offers non-GLP preclinical services, including LCMS bioanalysis, rodent in vivo studies, immunoanalytical services, and molecular assays. Its client-centric approach focuses on transparency and high-quality data delivery, supporting a wide range of drug modalities and fostering close collaboration with clients in major biotech hubs.